This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

Jiri Vajsar, MD; Avril Sloane, MB, BCh; Ellen Wood, MD; E. Gordon Murphy, MD
Toronto, Ontario

Arch Pediatr Adolesc Med. 1994;148(11):1210-1212.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

Plasmapheresis (PE) is effective in the treatment of Guillain-Barré syndrome (GBS), but it may be technically difficult to perform in children. We have shown that high-dose intravenous (IV) immunoglobulin is also effective in the treatment of childhood GBS.¹ To compare the therapeutic efficacy of IV immunoglobulin and PE, we retrospectively reviewed the charts of 15 consecutive children with a severe form of GBS (functional disability score of grade 4 or worse) who were treated with one of these methods.

Patient Reports. Seven girls and eight boys were treated during the past 5 years. Their mean age was 10.7 years (range, 4 to 16 years). All the children met the National Institute of Neurological and Communicative Disorders and Stroke criteria for the diagnosis of GBS.² All patients, except one with normal laboratory results, had characteristic cerebrospinal fluid abnormalities. Furthermore, all patients had at least one abnormality on nerve conduction . . . [Full Text PDF of this Article]

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?